Publications by authors named "Giulia Scotto"

Claim this Profile
T
Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers.
Giulia Scotto, Anna Galatà, Robert Fruscio, Giulia Besana, Fabio Landoni

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study.
Margherita Turinetto, Andrea Ricotti, Claudia Marchetti, Carmela Pisano, Claudio Zamagni, Giulia Scotto

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
Andrea Milani, Valentina Tuninetti, Sandro Pignata, Domenica Lorusso, Daniele Castaldo, Giulia Scotto

Tumori· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Francesca Corti, Maria Pia Brizzi, Vito Amoroso, Dario Giuffrida, Francesco Panzuto, Giulia Scotto

BMC Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience.
Valentina Tuninetti, Luca Pace, Eleonora Ghisoni, Virginia Quarà, Francesca Arezzo, Giulia Scotto

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Giulia Scotto

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.
Fulvio Borella, Stefano Cosma, Domenico Ferraioli, Isabelle Ray-Coquard, Nicolas Chopin, Giulia Scotto

Ann Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.
Fulvio Borella, Stefano Cosma, Domenico Ferraioli, Isabelle Ray-Coquard, Nicolas Chopin, Giulia Scotto

Ann Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.
Gaia Giannone, Daniele Castaldo, Valentina Tuninetti, Giulia Scotto, Margherita Turinetto

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia.
Fulvio Borella, Stefano Cosma, Domenico Ferraioli, Mario Preti, Niccolò Gallio, Giulia Scotto

Front Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
Margherita Turinetto, Anna A Valsecchi, Valentina Tuninetti, Giulia Scotto, Fulvio Borella

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells.
Sonia Capellero, Jessica Erriquez, Chiara Battistini, Roberta Porporato, Giulia Scotto

Int J Mol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer.
Giulia Scotto, Fulvio Borella, Margherita Turinetto, Valentina Tuninetti, Anna A Valsecchi

Cells· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality.
Margherita Turinetto, Giulia Scotto, Valentina Tuninetti, Gaia Giannone, Giorgio Valabrega

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy.
Giorgio Valabrega, Giulia Scotto, Valentina Tuninetti, Arianna Pani, Francesco Scaglione

Int J Mol Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis.
Fulvio Borella, Luca Bertero, Antonio Morrone, Alessandro Gambella, Marialuisa Bovetti, Giulia Scotto

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.
Valentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, Furio Maggiorotto, Manuela Robella, Giulia Scotto

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.
Gaia Giannone, Eleonora Ghisoni, Sofia Genta, Giulia Scotto, Valentina Tuninetti

Int J Mol Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.
Gloria Mittica, Margherita Goia, Angela Gambino, Giulia Scotto, Mattia Fonte

J Ovarian Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications.
Gaia Giannone, Laura Attademo, Giulia Scotto, Sofia Genta, Eleonora Ghisoni

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib: a new therapeutic option in ovarian cancer?
Eleonora Ghisoni, Gaia Giannone, Valentina Tuninetti, Sofia Genta, Giulia Scotto

Future Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.
Gaia Giannone, Valentina Tuninetti, Eleonora Ghisoni, Sofia Genta, Giulia Scotto

Int J Mol Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor status predicts development of brain metastases in ovarian cancers.
Gloria Mittica, Rebecca Senetta, Giulia Scotto, Massimo Aglietta, Furio Maggiorotto

Oncotarget· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis